Anal and Colorectal Cancer Market Report

Global and Region Anal and Colorectal Cancer Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：162
  • REPORT CODE：GMM1015723
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Anal and Colorectal Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Anal and Colorectal Cancermarket, defines the market attractiveness level of Anal and Colorectal Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Anal and Colorectal Cancer industry, describes the types of Anal and Colorectal Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anal and Colorectal Cancer market and the development prospects and opportunities of Anal and Colorectal Cancer industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anal and Colorectal Cancer market in Chapter 13.

    By Player:

    • EDP Biotech

    • Atara Biotherapeutics

    • Bayer

    • Immunovaccine

    • Amgen

    • Advaxis

    • Epigenomics

    • Clinical Genomics

    • BeiGene

    • Merck

    • Alere

    • Exact Sciences

    • Beckman Coulter

    • Eli Lilly

    • Abbott Diagnostics

    • ISA Pharmaceuticals

    • Boehringer Ingelheim

    • Metabiomics

    • Genomictree

    By Type:

    • Surgery

    • Radiation therapy

    • Colorectal cancer chemotherapy

    • Targeted therapy

    • Immunotherapy

    By End-User:

    • Hospitals

    • Ambulatory surgery centers

    • Cancer research centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Anal and Colorectal Cancer Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Anal and Colorectal Cancer Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Anal and Colorectal Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Anal and Colorectal Cancer Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Anal and Colorectal Cancer Market Analysis and Outlook to 2022

    • 7.1 Global Anal and Colorectal Cancer Consumption (2017-2022)

    • 7.2 United States Anal and Colorectal Cancer Consumption (2017-2022)

    • 7.3 Europe Anal and Colorectal Cancer Consumption (2017-2022)

    • 7.4 China Anal and Colorectal Cancer Consumption (2017-2022)

    • 7.5 Japan Anal and Colorectal Cancer Consumption (2017-2022)

    • 7.6 India Anal and Colorectal Cancer Consumption (2017-2022)

    • 7.7 South Korea Anal and Colorectal Cancer Consumption (2017-2022)

    8 Region and Country-wise Anal and Colorectal Cancer Market Analysis and Outlook to 2028

    • 8.1 Global Anal and Colorectal Cancer Consumption Forecast (2022-2028)

    • 8.2 United States Anal and Colorectal Cancer Consumption Forecast (2022-2028)

    • 8.3 Europe Anal and Colorectal Cancer Consumption Forecast (2022-2028)

    • 8.4 China Anal and Colorectal Cancer Consumption Forecast (2022-2028)

    • 8.5 Japan Anal and Colorectal Cancer Consumption Forecast (2022-2028)

    • 8.6 India Anal and Colorectal Cancer Consumption Forecast (2022-2028)

    • 8.7 South Korea Anal and Colorectal Cancer Consumption Forecast (2022-2028)

    9 Global Anal and Colorectal Cancer Market Outlook by Types and Applications to 2022

    • 9.1 Global Anal and Colorectal Cancer Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Surgery Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Radiation therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Colorectal cancer chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Targeted therapy Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Anal and Colorectal Cancer Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory surgery centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cancer research centers Consumption and Growth Rate (2017-2022)

    10 Global Anal and Colorectal Cancer Market Outlook by Types and Applications to 2028

    • 10.1 Global Anal and Colorectal Cancer Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Radiation therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Colorectal cancer chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Targeted therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Anal and Colorectal Cancer Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory surgery centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cancer research centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Anal and Colorectal Cancer Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Anal and Colorectal Cancer Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Anal and Colorectal Cancer Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Anal and Colorectal Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Anal and Colorectal Cancer Market Competitive Analysis

    • 14.1 EDP Biotech

      • 14.1.1 EDP Biotech Company Details

      • 14.1.2 EDP Biotech Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 EDP Biotech Anal and Colorectal Cancer Product and Service

    • 14.2 Atara Biotherapeutics

      • 14.2.1 Atara Biotherapeutics Company Details

      • 14.2.2 Atara Biotherapeutics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Atara Biotherapeutics Anal and Colorectal Cancer Product and Service

    • 14.3 Bayer

      • 14.3.1 Bayer Company Details

      • 14.3.2 Bayer Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer Anal and Colorectal Cancer Product and Service

    • 14.4 Immunovaccine

      • 14.4.1 Immunovaccine Company Details

      • 14.4.2 Immunovaccine Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Immunovaccine Anal and Colorectal Cancer Product and Service

    • 14.5 Amgen

      • 14.5.1 Amgen Company Details

      • 14.5.2 Amgen Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Amgen Anal and Colorectal Cancer Product and Service

    • 14.6 Advaxis

      • 14.6.1 Advaxis Company Details

      • 14.6.2 Advaxis Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Advaxis Anal and Colorectal Cancer Product and Service

    • 14.7 Epigenomics

      • 14.7.1 Epigenomics Company Details

      • 14.7.2 Epigenomics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Epigenomics Anal and Colorectal Cancer Product and Service

    • 14.8 Clinical Genomics

      • 14.8.1 Clinical Genomics Company Details

      • 14.8.2 Clinical Genomics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Clinical Genomics Anal and Colorectal Cancer Product and Service

    • 14.9 BeiGene

      • 14.9.1 BeiGene Company Details

      • 14.9.2 BeiGene Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 BeiGene Anal and Colorectal Cancer Product and Service

    • 14.10 Merck

      • 14.10.1 Merck Company Details

      • 14.10.2 Merck Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck Anal and Colorectal Cancer Product and Service

    • 14.11 Alere

      • 14.11.1 Alere Company Details

      • 14.11.2 Alere Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Alere Anal and Colorectal Cancer Product and Service

    • 14.12 Exact Sciences

      • 14.12.1 Exact Sciences Company Details

      • 14.12.2 Exact Sciences Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Exact Sciences Anal and Colorectal Cancer Product and Service

    • 14.13 Beckman Coulter

      • 14.13.1 Beckman Coulter Company Details

      • 14.13.2 Beckman Coulter Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Beckman Coulter Anal and Colorectal Cancer Product and Service

    • 14.14 Eli Lilly

      • 14.14.1 Eli Lilly Company Details

      • 14.14.2 Eli Lilly Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Eli Lilly Anal and Colorectal Cancer Product and Service

    • 14.15 Abbott Diagnostics

      • 14.15.1 Abbott Diagnostics Company Details

      • 14.15.2 Abbott Diagnostics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Abbott Diagnostics Anal and Colorectal Cancer Product and Service

    • 14.16 ISA Pharmaceuticals

      • 14.16.1 ISA Pharmaceuticals Company Details

      • 14.16.2 ISA Pharmaceuticals Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 ISA Pharmaceuticals Anal and Colorectal Cancer Product and Service

    • 14.17 Boehringer Ingelheim

      • 14.17.1 Boehringer Ingelheim Company Details

      • 14.17.2 Boehringer Ingelheim Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Boehringer Ingelheim Anal and Colorectal Cancer Product and Service

    • 14.18 Metabiomics

      • 14.18.1 Metabiomics Company Details

      • 14.18.2 Metabiomics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Metabiomics Anal and Colorectal Cancer Product and Service

    • 14.19 Genomictree

      • 14.19.1 Genomictree Company Details

      • 14.19.2 Genomictree Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Genomictree Anal and Colorectal Cancer Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Anal and Colorectal Cancer

    • Figure Anal and Colorectal Cancer Picture

    • Table Global Anal and Colorectal Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Anal and Colorectal Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Anal and Colorectal Cancer Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Anal and Colorectal Cancer Consumption by Country (2017-2022)

    • Figure United States Anal and Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Table Europe Anal and Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure China Anal and Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Japan Anal and Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure India Anal and Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure South Korea Anal and Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Anal and Colorectal Cancer Consumption Forecast by Country (2022-2028)

    • Figure United States Anal and Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Anal and Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Anal and Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Anal and Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Anal and Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Anal and Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal cancer chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory surgery centers Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer research centers Consumption and Growth Rate (2017-2022)

    • Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal cancer chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory surgery centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer research centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Anal and Colorectal Cancer Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Anal and Colorectal Cancer Export by Region (Top 5 Countries) (2017-2028)

    • Table EDP Biotech (Foundation Year, Company Profile and etc.)

    • Table EDP Biotech Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table EDP Biotech Anal and Colorectal Cancer Product and Service

    • Table Atara Biotherapeutics (Foundation Year, Company Profile and etc.)

    • Table Atara Biotherapeutics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atara Biotherapeutics Anal and Colorectal Cancer Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Anal and Colorectal Cancer Product and Service

    • Table Immunovaccine (Foundation Year, Company Profile and etc.)

    • Table Immunovaccine Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunovaccine Anal and Colorectal Cancer Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Anal and Colorectal Cancer Product and Service

    • Table Advaxis (Foundation Year, Company Profile and etc.)

    • Table Advaxis Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advaxis Anal and Colorectal Cancer Product and Service

    • Table Epigenomics (Foundation Year, Company Profile and etc.)

    • Table Epigenomics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epigenomics Anal and Colorectal Cancer Product and Service

    • Table Clinical Genomics (Foundation Year, Company Profile and etc.)

    • Table Clinical Genomics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clinical Genomics Anal and Colorectal Cancer Product and Service

    • Table BeiGene (Foundation Year, Company Profile and etc.)

    • Table BeiGene Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table BeiGene Anal and Colorectal Cancer Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Anal and Colorectal Cancer Product and Service

    • Table Alere (Foundation Year, Company Profile and etc.)

    • Table Alere Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alere Anal and Colorectal Cancer Product and Service

    • Table Exact Sciences (Foundation Year, Company Profile and etc.)

    • Table Exact Sciences Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exact Sciences Anal and Colorectal Cancer Product and Service

    • Table Beckman Coulter (Foundation Year, Company Profile and etc.)

    • Table Beckman Coulter Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckman Coulter Anal and Colorectal Cancer Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Anal and Colorectal Cancer Product and Service

    • Table Abbott Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Abbott Diagnostics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Diagnostics Anal and Colorectal Cancer Product and Service

    • Table ISA Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table ISA Pharmaceuticals Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table ISA Pharmaceuticals Anal and Colorectal Cancer Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Anal and Colorectal Cancer Product and Service

    • Table Metabiomics (Foundation Year, Company Profile and etc.)

    • Table Metabiomics Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Metabiomics Anal and Colorectal Cancer Product and Service

    • Table Genomictree (Foundation Year, Company Profile and etc.)

    • Table Genomictree Anal and Colorectal Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomictree Anal and Colorectal Cancer Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US